In the published article, there was an error regarding the affiliation details of all authors and order of affiliations, as shown below.
Instead of the following:
Ya-Nan Pi1,2, Wen-Cai Qi1, Bai-Rong Xia1*, Ge Lou2*and Wei-Lin Jin3*
1 Department of Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
2 Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China
3 Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, China
The affiliation list should read as follows:
Ya-Nan Pi1, Wen-Cai Qi2, Bai-Rong Xia2*, Ge Lou1*and Wei-Lin Jin3*
1 Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China
2 Department of Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
3 Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, China
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
lncRNA, tumor microenvironment, immunosuppression, immune escape, therapeutic target
Citation
Pi Y-N, Qi W-C, Xia B-R, Lou G and Jin W-L (2022) Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential. Front. Immunol. 13:891942. doi: 10.3389/fimmu.2022.891942
Received
08 March 2022
Accepted
11 March 2022
Published
08 April 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Pi, Qi, Xia, Lou and Jin.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ge Lou, louge@ems.hrbmu.edu.cn; Bai-Rong Xia, xiabairong@ustc.edu.cn; Wei-Lin Jin, weilinjin@yahoo.com; ldyy_jinwl@lzu.edu.cn
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.